San Francisco Bay Area biotech advances Phase I-II cancer immunotherapy trial with Fortrea
A San Francisco Bay Area biotech company approached Fortrea to manage a Phase I-II clinical trial evaluating a personalized, neoantigen-based vaccine.
Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial
- Read more about Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial
This case study demonstrates how Fortrea developed a novel approach to successfully delivery a large, industry-sponsored Phase III clinical trial to prevent hospitalization of infants due to a seasonal and dangerous illness.
Applying a patient- and site-centric approach in an early Phase I Alzheimer’s disease study
This case study discusses how Fortrea applied creative problem-solving to work though inherent challenges and shares a unique enrollment strategy for supporting sites and patients.
Digital transformation in market access Case Study
Digital transformation is a grand phase—it can cover technological innovation, data and processes and even global organizational change, yet it doesn't have to be a daunting prospect left to those loooknig for systemic change at a company level.
Delivering timely data with a biomarker data management system
By designing and implementing customized processes for your biomarker date management system, we can help you power clear, confident decisions in your studies.
Building stronger protections against fraudulent use of patient assistance programs
When recent evidence revealed fraudulent use of Hub and PAP for hepatitis C virus (HCV) and human immunodeficiency virus, we were ready to take action.
Providing site support with Fortrea Mobile Clinical Services (MCS) to enhance enrollment
This case study shares how the Mobile Clinical Studies team at Fortera helped enhance a sponsor's patient recruitment approach by providing site support services at key invesigator sites.
Carrie Thompson
Director, Strategic Delivery & Growth
Carrie Thompson is a Director in Strategic Delivery & Growth for Infectious Diseases and Critical Care and is based in Sheffield, UK. Carrie has over 18 years of clinical research experience, 14 of which with Fortrea. Her experience working in CROs and investigator-led settings, includes Phase I-III clinical trial execution, delivery and strategy. Carrie’s therapeutic experience spans multiple areas, including hematology, rare diseases and IBD. For the last six years, Carrie’s therapeutic focus has been infectious diseases, specializing in CHB with expertise in hybrid and platform study designs, overseeing operational delivery at a global level.
Carrie earned her MSc degree in Clinical Research at the Welsh School of Pharmacy, Cardiff, S. Wales and completed an executive MBA programme at York St John University, UK in 2022.Sonia is a certified Green Belt in Six Sigma and has been certified as a Project Management Professional (PMP) since 2003 and remains an active member of the Project Management Institute. She earned her master’s degree in operational management from the University of Washington. She joined our company in 2006.